SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jun 28, 16:01
3489.05
14.60 (+0.42%)
VOLUME 486
AVERAGE VOLUME
5-Day 731
10-Day 663
30-Day 606
VOLUME SHOCKER
5-Day 731
10-Day 663
30-Day 606
Prev. Close
3474.45
Open Price
3483.20
Bid PRICE (QTY.)
3489.05 (14)
Offer PRICE (Qty.)
3489.05 (6)
VWAP 3495.33
Market
Depth

Market Depth (28 Jun 2016)

BUY SELL
QTY PRICE PRICE QTY
2 3485.05 3503.00 18
6 3485.00 3507.00 1
1 3482.00 3509.80 1
3 3481.00 3510.00 17
7 3479.45 3515.00 2
402 Total 202 Total

Buy Qty

402

Sell QTY

202

Today's Low/High 3483.20 3506.00
52 Wk Low/High 3035.65 3850.00
L/U Price Band 2,779.60 4,169.30
LIVE
NSE
Jun 28, 16:01
3503.85
13.70 (+0.39%)
VOLUME 3,236
AVERAGE VOLUME
5-Day 8,215
10-Day 5,795
30-Day 5,082
VOLUME SHOCKER
5-Day 8,215
10-Day 5,795
30-Day 5,082
Prev. Close
3490.15
Open Price
3498.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
3503.85 (46)
VWAP 3498.04
Today's Low/High 3476.00 3512.00
52 Wk Low/High 3032.05 3872.00
L/U Price Band 2,792.15 4,188.15
Action in GlaxoSmithKline Pharmaceuticals

No recommendations so far.

What's your call on GlaxoSmithKline today?
Read Investor view

Consolidated
MARKET CAP (Rs Cr)
29,553.31
P/E
-
BOOK VALUE (Rs)
260.42
DIV (%)
625.00%
Market Lot
1
INDUSTRY P/E
25.65
EPS (TTM)
* -
P/C
-
PRICE/BOOK
13.40
DIV YIELD.(%)
1.79%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
38.51 new
DELIVERY AVERAGES
3-Day 58.83%
5-Day 54.31%
8-Day 56.75%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track GlaxoSmithKline on the go with moneycontrol app
UPCOMING CORPORATE ACTION
AGM
on 28-Jul-16 (Rs.50.0000 per share(500%)Dividend)
Book Closure
From 19-Jul-16 to 28-Jul-16 for Rs.50.0000 per share(500%)Dividend
Ex-Dividend
on 15-Jul-2016(Final 500.00%)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

28 June 2016

buy

Ceat Jun Fut

Entry Price (Rs)

799.80

Exit Price (Rs)

812.00

Gain (Rs)

12.00

buy

BPCL Jun Fut

Entry Price (Rs)

1,030.00

Exit Price (Rs)

1,042.00

Gain (Rs)

12.00

buy

Siemens Jun Fut

Entry Price (Rs)

1,281.00

Exit Price (Rs)

1,290.50

Gain (Rs)

10.00

buy

Lupin Jun Fut

Entry Price (Rs)

1,500.00

Exit Price (Rs)

1,514.00

Gain (Rs)

14.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 3268.65 3483.20  
High Price 3298.00 3506.00  
Low Price 3227.75 3483.20  
Last Price 3281.85 3489.05 6.31
Volume 1,083 486 -55.12
Simple Moving Averages
Days BSE NSE
30 3472.38 3482.03
50 3530.75 3540.19
150 3383.40 3392.45
200 3360.82 3369.55

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for GlaxoSmithKline

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Mar'16 Dec'15 Sep'15
Jun'15
Net Sales 686.06 728.70 691.90 621.85
Other Income 24.13 26.47 31.34 39.88
PBDIT 128.91 109.57 128.87 110.01
Net Profit 105.98 79.90 96.05 93.28

Annual Report

Download in PDF format 2015 |2011 |2010
Balance Sheet
Mar'15
(In Rs Cr)
Total Share Capital 84.70
Net Worth 1,851.67
Total Debt 2.63
Net Block 123.06
Investments 47.67
Total Assets 1,854.30
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 766.20 -0.99 965.15 706.40 184,405.49
Lupin 1543.30 4.39 2127.00 1294.05 69,578.05
Dr Reddys Labs 3265.75 0.77 4382.95 2750.00 55,716.48
Aurobindo Pharm 730.05 1.00 891.50 618.00 42,720.31
Cipla 496.85 1.61 748.00 458.25 39,927.10
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 15Sep' 15Jun' 15Mar' 15
Promoter75.0075.0075.0075.00
Public (FII + DII)25.0025.0025.0025.00
Others0.000.000.000.00
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Dr. Annie Besant Road ,
City
Mumbai
State
Maharashtra
Pin Code
400030
Tel. No.
022-24959595
Fax No.
022-24959494
Email:
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Telangana
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
D S Parekh
Chairman
H B Joshipura
Managing Director
A Aristidou
Director
R R Bajaaj
Director
A Bansal
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Heritage Foods Recommended on May 4th 2016

Recommended price 502.00  |  Peak from reco 572.75 14.15%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About GlaxoSmithKline

GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 29,553.31 crore.

The company management includes D S Parekh - Chairman, H B Joshipura - Managing Director, A Aristidou - Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, N Kaviratne - Director, R Krishnaswamy - Director, A N Roy - Director, R C Sequeira - Director, D Sundaram - Director, Regis Simard - Non Executive Director.

It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.

Its Registered office is at Dr. Annie Besant Road , Mumbai,Maharashtra - 400030.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of GlaxoSmithKline